8037 — China Biotech Services Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$356.14m
- HK$502.51m
- HK$70.51m
- 17
- 13
- 66
- 20
Annual cashflow statement for China Biotech Services Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 203 | 181 | 863 | -142 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 7 | 17.2 | -11.3 | 30.3 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 172 | -225 | -435 | 251 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 422 | 40.5 | 483 | 195 | — |
| Capital Expenditures | -127 | -12.2 | -122 | -62.9 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.352 | 4.09 | -135 | -4.65 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -126 | -8.12 | -256 | -67.5 | — |
| Financing Cash Flow Items | -3.79 | -219 | -303 | -162 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 43.9 | -267 | -282 | -146 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 339 | -234 | -57.8 | -20.7 | — |